Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature

Shefali Chopra, Nolan Maloney, Wei Lien Wang

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Epithelioid inflammatory myofibroblastic sarcomas are an aggressive variant of inflammatory myofibroblastic tumor described primarily in the abdomen and less commonly in pulmonary location. The anaplastic lymphoma kinase (ALK) fusion partners described in this tumor include RANB2, RRBP1 and EML4. While rare examples of inflammatory myofibroblastic tumors have been described in the central nervous system, the epithelioid variant has never been described. The ALK–VCL fusion has been described in renal cell carcinoma, high-grade glioma and epithelioid fibrous histiocytoma but has not been described in epithelioid inflammatory myofibroblastic sarcoma or even inflammatory myofibroblastic tumor. Herein, we report the first case of epithelioid inflammatory myofibroblastic sarcoma in the central nervous system as well as the first case with VCL as the fusion partner for ALK.

Original languageEnglish (US)
Pages (from-to)35-42
Number of pages8
JournalBrain tumor pathology
Volume39
Issue number1
DOIs
StatePublished - Jan 2022

Keywords

  • ALK–VCL fusion
  • Central nervous system
  • Epithelioid inflammatory myofibroblastic sarcoma

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature'. Together they form a unique fingerprint.

Cite this